COVID-19: molecular and serological detection methods

PeerJ

article

Ahmed E. Dhamad¹  Muna A. Abdal Rhida¹ 

[1] Cell and Molecular Biology, University of Arkansas at Fayetteville;Department of Biological Sciences, Wasit University

关键词: COVID-19;    SARS-CoV-2;    rRT-PCR;    ID NOW COVID-19;    Isothermal amplification;    CRISPR-Cas12;    LFA;    ELISA;   

DOI  :  10.7717/peerj.10180

学科分类：社会科学、人文和艺术（综合）

来源: Inra

【 摘 要 】

Since COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared as a pandemic disease by the World Health Organization in early 2020, many countries, organizations and companies have tried to find the best way to diagnose the virus and contain its spreading. SARS-CoV-2 is a positive-sense single RNA (+ssRNA) coronavirus and mainly spreads through droplets, respiratory secretions, and direct contact. The early detection of the virus plays a central role in lowering COVID19 incidents and mortality rates. Thus, finding a simple, accurate, cheap and quick detection approach for SARS-CoV-2 at early stage of the viral infection is urgent and at high demand all around the world. The Food and Drug Administration and other health agencies have declared Emergency Use Authorization to develop diagnostic methods for COVID-19 and fulfill the demand. However, not all developed methods are appropriate and selecting a suitable method is challenging. Among all detection methods, rRT-PCR is the gold standard method. Unlike molecular methods, serological methods lack the ability of early detection with low accuracy. In this review, we summarized the current knowledge about COVID-19 detection methods aiming to highlight the advantages and disadvantages of molecular and serological methods.

【 授权许可】

CC BY